Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 26
  • Start Date: October 2021
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 2
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: August 2021
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other, Behavioral
  • Participants: 39
  • Start Date: July 1, 2021
A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 200
  • Start Date: June 2021
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 100
  • Start Date: May 3, 2021
Diagnostic échographique Non-invasif Des Maladies Chroniques du Foie en Consultation d'hépatologie
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 28
  • Start Date: May 2021
A Phase I Single Dose Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement, Other
  • Participants: 60
  • Start Date: May 1, 2021
Interest in Combo (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 1250
  • Start Date: May 1, 2021
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 400
  • Start Date: May 2021
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: April 27, 2021
A Phase 1, Double Blind, Placebo Controlled, Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects
Showing 1-12 of 279